Drugs / Deep-sea fish oil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06392971 | Jan 2023 → Mar 2024 | esophageal cancer, esophagitis, radiation-induced disorder | First Affiliated Hospital of Chengdu Medical College | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Deep-sea fish oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06392971 ↗ |
| Route | Oral | “prophylactic oral deep-sea fish oil” NCT06392971 ↗ |